Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 92.24 Bone Resorption Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 06.02. FARMACOS QUE AFECTAN EL METABOLISMO OSEO | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 18.11 Calcium Metabolism Modifiers | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Biphosphonates | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 14. Antiinflamatorios no esteroideos, antirreumáticos, y agentes mineralizantes | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 09. GINECO - OBSTETRICIA | No observations |
| El Salvador - 2019 | DROGAS PARA EL TRATAMIENTO DE ENFERMEDADES OSEAS | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 92.24 Bone Resorption Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 09. GINECO - OBSTETRICIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | M. SISTEMA MUSCULOESQUELÉTICO | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | M. SISTEMA MUSCULOESQUELÉTICO | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 05. DROGAS PARA EL TRATAMIENTO DE ENFERMEDADES ÓSEAS | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 06.06.02 Bisphosphonates | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |